Pre-Seed · Biotech
Synakis Corp: Pre-Seed
Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage
Funding history
Pre-Seed · This roundCA$2.6M
Loading rounds…
Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage